MiNK Therapeutics, Inc.
INKT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $26 | $37 | $88 | $149 |
| - Cash | $5 | $3 | $20 | $39 |
| + Debt | $5 | $0 | $0 | $0 |
| Enterprise Value | $26 | $33 | $68 | $110 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$11 | -$22 | -$28 | -$28 |
| % Margin | – | – | – | – |
| Net Income | -$11 | -$22 | -$28 | -$30 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.8 | -6.54 | -8.31 | -9.03 |
| % Growth | 57.2% | 21.3% | 8% | – |
| Operating Cash Flow | -$10 | -$16 | -$19 | -$13 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$10 | -$16 | -$19 | -$13 |